Science
Mechanism of Action
Historically, styrene functioned as a solvent, facilitating the dissolution of various components within cosmetic formulations. It does not possess any known direct beneficial mechanism on the skin.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Transparency
Dusting Analysis
Styrene is not an active ingredient, and its presence in cosmetic formulations, even in trace residual amounts, is subject to strict regulatory oversight due to safety classifications, rendering 'dusting' an irrelevant concept for this substance.
The Formula
Formulation
Stability
Styrene undergoes slow polymerization at ambient temperatures, with the reaction rate increasing significantly above 65 °C. To mitigate violent polymerization, it typically requires stabilization with an inhibitor, such as tert-butylcatechol.
Conflicts
- strong oxidizing agents (peroxides)
- bases
- acids
- halides
- copper and copper alloys (due to corrosion risk)
Safety
Safety Profile
Styrene monomer is classified as a carcinogen by authoritative regulatory bodies including the International Agency for Research on Cancer (IARC), the National Toxicology Program (NTP), and California Proposition 65. Furthermore, the European Commission on Endocrine Disruption designates it as a Category 1 endocrine disruptor. Acute exposure can induce irritation of mucous membranes, eyes, and skin. Chronic exposure has been linked to central nervous system effects, hearing impairment, and nerve damage. California Assembly Bill No. 496 will prohibit its intentional addition to cosmetic products from January 1, 2027. While the Cosmetic Ingredient Review (CIR) Expert Panel concluded that styrene and vinyl-type styrene copolymers are safe, this finding specifically pertains to trace residual monomer levels within compliant polymers, which are deemed substantially below levels of concern and are not expected to be absorbed percutaneously.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Styrene monomer is classified as both a carcinogen and a Category 1 endocrine disruptor, presenting significant irritation risks and regulatory prohibitions, making it an ingredient to unequivocally avoid in skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…